Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Chemotherapy. Linköping University, Linköping, Sweden

Survival: 6.0 months
Toxicity Grade: 5
Treatments: Chemotherapy
Country: Sweden
City/State/Province: Linköping
Hospital: Linköping University
Journal: Link
Date: 9/2012

This phase 3 study involved newly diagnosed glioblastoma patients, all older than 60 years, who were divided into three separate treatment groups. Group A was composed of 93 patients with a median age of 70 years and 59% male. Group B had 98 patients with a median age of 70 years and 51% male. There were 100 patients in group C with a median age of 70 years and 68% male.

Patients in group A were treated with the chemotherapy agent temozolomide.
Patients in group B were treated with hypofractionated radiotherapy.
Patients in group C were treated with standard radiotherapy.

There was one treatment-related death in group A due to bleeding. Grade 4 neutropenia and thrombocytopenia were also reported.

The most severe toxicities in group B were of grade 4 and included seizures and fatigue.

There was one treatment-related death due to infection reported in group C. Grade 3 seizures were also reported.

The median overall survival rates for groups A, B, and C were 6.0, 8.3, and 7.5 months, respectively.

This study was partially supported by Merck.

Correspondence: Dr. Annika Malmström; email:

E-mail to a Friend Email Physician More Information